Abstract
In a comparison of dengue type 2 immune mouse ascitic fluid immunization schedules, a schedule in which adjuvant vaccines were not used produced neutralizing antibody titers that were specific and a mouse mortality rate that was lower, resulting in a greater yield of ascitic fluids. In the schedules in which emulsified adjuvant vaccines were used, the quality of the emulsion had little effect on antibody titer produced.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERLIN B. S., McKINNEY R. W. A simple device for making emulsified vaccines. J Lab Clin Med. 1958 Oct;52(4):657–658. [PubMed] [Google Scholar]
- Brandt W. E., Buescher E. L., Hetrick F. M. Production and characterization of arbovirus antibody in mouse ascitic fluid. Am J Trop Med Hyg. 1967 May;16(3):339–347. doi: 10.4269/ajtmh.1967.16.339. [DOI] [PubMed] [Google Scholar]
- CLARKE D. H., CASALS J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg. 1958 Sep;7(5):561–573. doi: 10.4269/ajtmh.1958.7.561. [DOI] [PubMed] [Google Scholar]
- Chappell W. A., Sasso D. R., Toole R. F., Monath T. P. Labile serum factor and its effect on arbovirus neutralization. Appl Microbiol. 1971 Jan;21(1):79–83. doi: 10.1128/am.21.1.79-83.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gamble W. C., Chappell W. A., George E. H. The comparison of viral antibody titers of acid-precipitated and non-precipitated mouse ascitic fluids. Health Lab Sci. 1978 Apr;15(2):91–94. [PubMed] [Google Scholar]
- Herbert W. J. The mode of action of mineral-oil emulsion adjuvants on antibody production in mice. Immunology. 1968 Mar;14(3):301–318. [PMC free article] [PubMed] [Google Scholar]
- Hierholzer J. C., Gamble W. C., Quist K. D., Chappell W. A. Comparison of immunization methods for producing reference adenovirus antisera in horses. Appl Microbiol. 1972 Sep;24(3):398–404. doi: 10.1128/am.24.3.398-404.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOCKEY S. D., BERG R. H. A SYRINGE CHURN FOR MAKING REPOSITORY EMULSIONS. ORIGINS, PRINCIPLES AND PERFORMANCE. Ann Allergy. 1964 Aug;22:410–417. [PubMed] [Google Scholar]
- PEARSON C. M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med. 1956 Jan;91(1):95–101. doi: 10.3181/00379727-91-22179. [DOI] [PubMed] [Google Scholar]
- Peck H. M., Woodhour A. F., Hilleman M. R. New metabolizable immunologic adjuvant for human use. 8. Chronic toxicity and teratogenic tests. Proc Soc Exp Biol Med. 1968 Jul;128(3):699–708. doi: 10.3181/00379727-128-33104. [DOI] [PubMed] [Google Scholar]
- ROTHBARD S., WATSON R. F. Amyloidosis and renal lesion induced in mice by injection with Freund-type of adjuvant. Proc Soc Exp Biol Med. 1954 Jan;85(1):133–137. doi: 10.3181/00379727-85-20808. [DOI] [PubMed] [Google Scholar]
- Rigdon R. H., Schadewald T. Bacteriological and pathological study of animals given Freund adjuvant. Appl Microbiol. 1972 Oct;24(4):634–637. doi: 10.1128/am.24.4.634-637.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Russell P. K., Nisalak A., Sukhavachana P., Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol. 1967 Aug;99(2):285–290. [PubMed] [Google Scholar]
- Sartorelli A. C., Fischer D. S., Downs W. G. Use of sarcoma 180/TG to prepare hyperimmune ascitic fluid in the mouse. J Immunol. 1966 Apr;96(4):676–682. [PubMed] [Google Scholar]
- Tikasingh E. S., Spence L., Downs W. G. The use of adjuvant and sarcoma 180 cells in the production of mouse hyperimmune ascitic fluids to arboviruses. Am J Trop Med Hyg. 1966 Mar;15(2):219–226. doi: 10.4269/ajtmh.1966.15.219. [DOI] [PubMed] [Google Scholar]